Proposed Changes to MA and Part D Prescription Drug Program Quality Rating System from the 2021 and 2022 Policy and Technical Changes Proposed Rule
In the 2021 and 2022 Policy and Technical Changes Proposed Rule, CMS is proposing routine measure updates and an increase in the weight of patient experience/complaints and access measures. It…
BluePeak AdvisorsFebruary 25, 2020